The Demineralized Bone Matrix Market is being driven by Increasing geriatric population globally
The Demineralized Bone Matrix Market is expected to grow at a CAGR of 7.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 521 million. The demineralized bone matrix (DBM) market is witnessing a wave of innovation, with companies introducing advanced DBM solutions for bone regeneration and repair. Notably, SeaSpine Holdings Corp. recently launched the OsteoTorrent and OsteoTorrent C DBM product lines in May 2022. These new offerings, based on SeaSpine's Evo3/OsteoSurge 300 DBMs, represent significant advancements in DBM technology. The OsteoTorrent families are engineered to deliver enhanced osteoinductive properties, essential for efficient bone healing and integration, catering to the burgeoning demand for effective treatments in orthopedics and reconstructive surgery.
Get more information on Demineralized Bone Matrix Market by requesting a sample report
The market is segmented based on segments_for_ai.nslist
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
200 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.3% |
Market growth 2025-2029 |
USD 521 million |
Market structure |
Fragmented |
YoY growth 2024-2025(%) |
7.2 |
Key countries |
US, UK, China, Germany, Canada, Japan, France, Brazil, Italy, and South Korea |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Demineralized Bone Matrix (DBM) market holds significant growth potential in the orthopedic sector, particularly in the context of orthopedic procedures for bone-related disorders. Minimally invasive surgeries, such as bone regeneration and spinal fusion surgeries, are key applications for DBM. Joint reconstruction, trauma care, and sports-related injuries also benefit from this allograft material. DBM serves as a bone graft substitute for osteoporosis, arthritis, and other orthopedic disorders, addressing the needs of an aging population. Autografts, which have limitations such as disease transmission and donor site morbidity, are being replaced by DBM in various orthopedic surgeries. Tissue engineering and regenerative medicine further expand the applications of DBM, enabling cartilage formation and bone formation in trauma surgery.
The Demineralized Bone Matrix (DBM) market is a significant segment within the broader global biotechnology industry, focusing on orthopedic applications such as orthopedic procedures, bone-related disorders, minimally invasive surgeries, bone regeneration, spinal fusion surgeries, joint reconstruction, trauma care, and sports-related injuries. This market's growth is driven by the increasing prevalence of bone-related conditions and the rising demand for advanced, cellular allografts and tissue engineering solutions. The global healthcare market, which includes manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is projected to expand due to demographic trends, including an aging population. By 2050, approximately one-quarter of the US population and Europe's population by 2030 are projected to be over 60 years old.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted